NEAT1 and cancer: Accumulating evidences have revealed that NEAT1 is dysregulated and acts as an unfavorable prognostic factor in human cancers including gliomas (Zhen et al., 2016), colorectal cancer (Wu et al., 2015), liver cancer (Wang et al., 2017), gallbladder cancer (Yang et al., 2020), and gastric cancer (Wang et al., 2018).